NCT01626664 2024-04-25KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)Kyowa Kirin Co., Ltd.Phase 2 Completed71 enrolled 15 charts
NCT04185220 2023-01-04Phase I Study of Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for People With Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sezary SyndromeNational Institutes of Health Clinical Center (CC)Phase 1 Completed6 enrolled 16 charts